These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26360089)

  • 1. Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people.
    Sahakian BJ; Morein-Zamir S
    Lancet Psychiatry; 2015 Apr; 2(4):357-62. PubMed ID: 26360089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.
    Sahakian BJ; Bruhl AB; Cook J; Killikelly C; Savulich G; Piercy T; Hafizi S; Perez J; Fernandez-Egea E; Suckling J; Jones PB
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1677):20140214. PubMed ID: 26240429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
    Kapur A
    CNS Drugs; 2020 Oct; 34(10):1045-1062. PubMed ID: 32794136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
    Fond G; Micoulaud-Franchi JA; Brunel L; Macgregor A; Miot S; Lopez R; Richieri R; Abbar M; Lancon C; Repantis D
    Psychiatry Res; 2015 Sep; 229(1-2):12-20. PubMed ID: 26187342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 10. The Mind Bending Quest for Cognitive Enhancers.
    Arce E; Ehlers MD
    Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
    Brady KT; Gray KM; Tolliver BK
    Pharmacol Biochem Behav; 2011 Aug; 99(2):285-94. PubMed ID: 21557964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
    Rozenek EB; Górska M; Wilczyńska K; Waszkiewicz N
    Arh Hig Rada Toksikol; 2019 Sep; 70(3):150-159. PubMed ID: 32597132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 14. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.
    Mereu M; Bonci A; Newman AH; Tanda G
    Psychopharmacology (Berl); 2013 Oct; 229(3):415-34. PubMed ID: 23934211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 16. Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain.
    Scoriels L; Jones PB; Sahakian BJ
    Neuropharmacology; 2013 Jan; 64():168-84. PubMed ID: 22820555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.
    Turner DC; Clark L; Pomarol-Clotet E; McKenna P; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1363-73. PubMed ID: 15085092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
    Bagot KS; Kaminer Y
    Addiction; 2014 Apr; 109(4):547-57. PubMed ID: 24749160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
    Repantis D; Schlattmann P; Laisney O; Heuser I
    Pharmacol Res; 2010 Sep; 62(3):187-206. PubMed ID: 20416377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.